Showing results (481-490 of 1,408) with videos related to

Sort By:
Pageof 141
Cell Biology International|April 25, 2000
Variability in E-selectin expression, mRNA levels and sE-selectin release between endothelial cell lines and primary endothelial cellsH F Galley, M G Blaylock, A M Dubbels, et al.
Clinical Science (London, England : 1979)|October 29, 2000
Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell lineH F Galley, J K Dhillon, R L Paterson, et al.
Postgraduate Medicine|September 10, 2011
Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsulesLynn R Webster, Randall Brewer, David Morris, et al.
The British Journal of Ophthalmology|July 1, 1995
Ischaemic retinopathy occurring in patients receiving bone marrow allografts and campath-1G: a clinicopathological studyA R Webster, J R Anderson, E M Richards, et al.
The British Journal of Ophthalmology|November 1, 1993
The effect of pilocarpine on the glaucomatous visual fieldA R Webster, A J Luff, C R Canning, et al.
British Journal of Anaesthesia|May 1, 1996
Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndromeA J Pittard, R E Banks, H F Galley, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1986
Relationship of metabolism of 2'-, 3'- and 5'-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferensD R Webster, G D Boston, N H Holford, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 14, 2017
Quantitative and Qualitative Features of Spectral-Domain Optical Coherence Tomography Provide Prognostic Indicators for Visual Acuity in Patients With ChoroideremiaAlessandro Abbouda, Wei Sing Lim, Lina Sprogyte, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 2, 2009
Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerationsD K Walker, J Davis, C Houle, et al.
Experimental Eye Research|January 10, 2017
Mechanism and evidence of nonsense suppression therapy for genetic eye disordersRose Richardson, Matthew Smart, Dhani Tracey-White, et al.
Pageof 141